USASpending / award record
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
Source: USASpending · CONT_AWD_75N91023F00001_7529_75N91019D00021_7529 · As of 2026-05-04 · Last synced 2026-11-10
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.
- source record id
- CONT_AWD_75N91023F00001_7529_75N91019D00021_7529
- generated unique award id
- CONT_AWD_75N91023F00001_7529_75N91019D00021_7529
- source
- USASpending
- award id piid
- 75N91023F00001
- vendor name as awarded
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
- vendor uei
- S3GMKS8ELA16
- agency name
- Department of Health and Human Services
- sub agency
- National Institutes of Health
- contract title or description
- FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
- naics code
- 541714
- naics description
- RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- psc code
- AN12
- texas nigp code
- Not published
- value obligated
- 1293012
- Total / ceiling as published (not obligated)
- Not published
- pop start date
- 2023-07-26T05:00:00.000Z
- expiry date
- 2026-12-25T06:00:00.000Z
- place of performance state
- TX
- recipient location state
- TX
- set aside type
- Not published
- source as of
- 2026-05-04T05:00:00.000Z
- last synced
- 2026-11-10T06:00:00.000Z
- published
- true
- Source expiry field
- Period of performance current end date (USASpending)